LKT Laboratories, Inc.

LKT Laboratories, Inc. logo

LKT Laboratories, Inc. is a research and development company focused on the discovery of specialty chemicals for cancer chemoprevention. We produce and distribute unique chemicals and biochemicals for all types of life science research and supply raw materials for manufacturing and repacking.

Company Website

Product Listing

Solanesol 50 mg  | ≥92%

LKT Laboratories, Inc.

All-trans nonaprenol isoprenoid, found in Solanaceae family plants, used as biomarker for combustible tobacco use or exposure.

More Information Supplier Page

Solanesol 100 mg  | ≥92%

LKT Laboratories, Inc.

All-trans nonaprenol isoprenoid, found in Solanaceae family plants, used as biomarker for combustible tobacco use or exposure.

More Information Supplier Page

Solanesol 500 mg  | ≥92%

LKT Laboratories, Inc.

All-trans nonaprenol isoprenoid, found in Solanaceae family plants, used as biomarker for combustible tobacco use or exposure.

More Information Supplier Page

Solanesol 10 mg  | ≥92%

LKT Laboratories, Inc.

All-trans nonaprenol isoprenoid, found in Solanaceae family plants, used as biomarker for combustible tobacco use or exposure.

More Information Supplier Page

Somatostatin-14 5 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-14 10 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-14 25 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-25 0.5 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-25 1 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-25 2.5 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-28 1 mg  | ≥98%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-28 (1-12) 1 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-28 (1-12) 2 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-28 (1-12) 5 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-28 (1-14) 1 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-28 (1-14) 2 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Somatostatin-28 (1-14) 5 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.

More Information Supplier Page

Spinorphin, cow 5 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous heptapeptide; P2X3 and N-formylpeptide antagonist, ACE, enkephalinase, aminopeptidase IV, neutral endopeptidase, DPP3 inhibitor.

More Information Supplier Page

Spinorphin, cow 10 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous heptapeptide; P2X3 and N-formylpeptide antagonist, ACE, enkephalinase, aminopeptidase IV, neutral endopeptidase, DPP3 inhibitor.

More Information Supplier Page

Spinorphin, cow 25 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous heptapeptide; P2X3 and N-formylpeptide antagonist, ACE, enkephalinase, aminopeptidase IV, neutral endopeptidase, DPP3 inhibitor.

More Information Supplier Page

Spironolactone 1 g  | ≥97%

LKT Laboratories, Inc.

Mineralocorticoid, aldosterone, AR antagonist, ENaC channel blocker, potential voltage-gated Ca2+ channel blocker.

More Information Supplier Page

Spironolactone 5 g  | ≥97%

LKT Laboratories, Inc.

Mineralocorticoid, aldosterone, AR antagonist, ENaC channel blocker, potential voltage-gated Ca2+ channel blocker.

More Information Supplier Page

Spironolactone 250 mg  | ≥97%

LKT Laboratories, Inc.

Mineralocorticoid, aldosterone, AR antagonist, ENaC channel blocker, potential voltage-gated Ca2+ channel blocker.

More Information Supplier Page